Sign inJoin waitlistJoin the waitlist

AM

Anita Mamtani

Surgical Site Director, MSK Bergen · New York Presbyterian Hospital

Credentials: · · · · ·

History

Memorial Sloan Kettering Bergen
2022–Present

Complex General Surgical Oncology
Memorial Sloan Kettering Cancer Center
2017–2019
General Surgery
Beth Israel Deaconess Medical Center
2012–2017
Sidney Kimmel Medical College at Thomas Jefferson University
2008–2012

Research

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
Annals of Surgical Oncology · 2016 · First of 14 authors · 252 citations
Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event
JAMA Oncology · 2021 · 139 citations
Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients
Annals of Surgery · 2017 · 94 citations

MM
Monica Morrow
38 papers
AB
Andrea Barrio
21 papers
Mary Gemignani
10 papers
KZ
Kimberly Van Zee
8 papers
AH
Alexandra Heerdt
7 papers
AT
Audree Tadros
7 papers
ME
Mahmoud El-Tamer
6 papers
Melissa Pilewskie
6 papers
VS
Virgilio Sacchini
6 papers
George Plitas
5 papers
Giacomo Montagna
5 papers
HC
Hiram Cody
5 papers

Clinical trials

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2026–2030
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2021–2027